Jane Street’s Cyclerion Therapeutics CYCN Stock Holding History

Jane Street’s Portfolio CYCN Stock Details CYCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,364	Closed	-$55.1K	–	8747
2023 Q2	$55.1K	Buy	+13,364	New	+$69.2K	﹤0.01%	8188
2023 Q1	–	Sell	-1,273	Closed	-$16.7K	–	9171
2022 Q4	$16.7K	Buy	+1,273	New	+$15.1K	﹤0.01%	8647
2022 Q3	–	Sell	-2,915	Closed	-$32K	–	9812
2022 Q2	$32K	Buy	+2,915	New	+$41.8K	﹤0.01%	9038
2021 Q4	–	Sell	-830	Closed	-$51K	–	10167
2021 Q3	$51K	Buy	+830	New	+$54.3K	﹤0.01%	9540

Other funds holding CYCN

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street's CYCN Position: Q3 2023 in Review

Jane Street sold out of Cyclerion Therapeutics (CYCN) in Q3 2023, closing a stake of 13,364 shares — an estimated $55.1K sold.

Jane Street first reported a position in CYCN in Q3 2021 and held it in 4 quarters. The position peaked at $55.1K in Q2 2023. 17 funds tracked by Wall St. Rank hold CYCN as of Q3 2023.

Jane Street reported no remaining Cyclerion Therapeutics position as of Q3 2023 after selling out during the quarter.
Jane Street sold 13,364 Cyclerion Therapeutics shares in Q3 2023, an estimated $55.1K.
Jane Street first reported a position in Cyclerion Therapeutics in Q3 2021 and held it in 4 quarters.
Jane Street's Cyclerion Therapeutics position peaked at $55.1K in Q2 2023.
17 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.